## REVIEWER A — domain expert

**Strengths:** The project is technically sound, leveraging a well-chosen set of existing hardware (Zeiss IM 35, Quantel laser, sCMOS camera) and building a modular open-source control stack. The preliminary data (positioning repeatability ±0.3 µm, live-cell phototoxicity <5%, false-positive rate 1.5%) are convincing for a tool-development stage. The team’s combined experience in automated microscopy, firmware, computer vision, and laser safety is excellent. The success metrics are quantitative and realistic. Weaknesses are minor: the AI-agent’s claimed advantage over μManager is marginal in simple tasks; the offline fallback is still heavily reliant on pre-cached decisions. Overall, a well-prepared concept with high feasibility.

| Criterion | Score (1-5) |
|-----------|-------------|
| Impact | 4 |
| Approach | 4 |
| Innovation | 4 |
| Preliminary Data | 4 |
| PI & Team | 5 |
| Feasibility | 4 |
| Experimental Design | 4 |
| Budget | 4 |
| Clarity | 5 |
| Ethics | 5 |
| Overall | 4 |

**Score Sum: 47/55**

---

## REVIEWER B — fluff/impact auditor

**Strengths:** The document is clear, budgets are itemized, and safety protocols are thorough. The open-source commitment is a plus, but the actual impact is limited: the system is a custom rig that only a small number of labs with similar vintage microscopes could replicate. The biological testbed (Elodea chloroplasts) has no direct connection to the stated long-term goals (centriole biology, longevity). The innovation is incremental—LLM integration for microscope control is a natural extension of existing work, not a breakthrough. Preliminary data are adequate but small-scale. The team is competent but lacks a strong track record in open-source hardware dissemination. Feasibility is moderate given API dependency and the need for 24/7 unattended operation.

| Criterion | Score (1-5) |
|-----------|-------------|
| Impact | 3 |
| Approach | 3 |
| Innovation | 3 |
| Preliminary Data | 3 |
| PI & Team | 3 |
| Feasibility | 3 |
| Experimental Design | 4 |
| Budget | 4 |
| Clarity | 4 |
| Ethics | 4 |
| Overall | 3 |

**Score Sum: 37/55**

---

## REVIEWER C — red team

**Strengths:** Excellent clarity, detailed risk mitigation, and strong laser safety planning. The budget is realistic. **Critical weaknesses:** The AI-agent is overhyped—the “scientific reasoning” is simply following pre‑defined tool calls, not true reasoning; the benchmark shows only a 0.3 s advantage over a scripted OpenCV pipeline. The preliminary live-cell data (n=50 chloroplasts) is too small to reliably estimate phototoxicity or false-positive rates. The watchdog/offline fallback still leaves the system vulnerable to LLM hallucinations and API outages, undermining the claim of robust 24/7 autonomy. No contingency plan for the case that the LLM provider changes pricing or discontinues service. The project’s direct contribution to biology or tool dissemination is unclear; it is essentially a commissioning exercise.

| Criterion | Score (1-5) |
|-----------|-------------|
| Impact | 2 |
| Approach | 3 |
| Innovation | 2 |
| Preliminary Data | 2 |
| PI & Team | 4 |
| Feasibility | 2 |
| Experimental Design | 3 |
| Budget | 4 |
| Clarity | 5 |
| Ethics | 4 |
| Overall | 2 |

**Score Sum: 33/55**

---

## Combined Verdict

**Combined Score: MIN = 33/55**

**Recommendation: Major Revisions**

**Top 3 Actions:**
1. **Validate AI agent reliability at scale** – Run a minimum of 1,000 closed-loop cycles on a test target under realistic conditions (including network interruptions, partial occlusions, and random delay injection). Report false-positive/false-negative rates, decision latency distribution, and recovery time from failures.  
2. **Strengthen API dependency resilience** – Provide a detailed architecture for a fully offline fallback that does not rely on a single LLM provider (e.g., a local lightweight model or a rule‑based engine for standard scenarios). Demonstrate that the system can operate for at least 72 hours without internet access.  
3. **Expand preliminary biological data** – Increase the sample size for phototoxicity and ablation success to at least 300 chloroplasts across multiple days. Include positive and negative controls (e.g., sham irradiation, known phototoxic doses) to quantify assay sensitivity and variability.